TrumpRx, the Trump administration’s much-anticipated direct-to-consumer drug platform, went live on Thursday. However, it ...
Generic drugmakers settle inflated prices claim by paying $18 million and adopting antitrust compliance reforms in a decade-long Connecticut lawsuit.
Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...
CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...
President Trump signed a $1.2 trillion spending package this week, provisions of which could radically change the way ...
Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...
Senate Democrats are advancing a new prescription drug pricing agenda they say would lower costs for patients, reduce wasteful health care spending, and strengthen US biomedical innovation, while ...
WASHINGTON - Skyrocketing drug costs became the stuff of congressional hearings and presidential campaign speeches in 2015, and not only because of the brash Martin Shkrelis of the world. The federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results